Last updated: March 7, 2025
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Overall Status: Active - Recruiting
Phase
N/A
Condition
Williams Syndrome
Asperger's Disorder
Treatment
N/AClinical Study ID
NCT05989685
LPEK-0659
Ages 13-21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria study group:
- patients who meet the principal diagnosis of ASD, which includes atypical autism (ICD-10: F84.1) and Asperger syndrome (ICD-10: F84.5), and are between the ages of 13 and 21 years old.
Exclusion Criteria study group:
Dementia / below average cognitive abilities (IQ < 85)
lack of German language skills
severe visual or hearing impairment (uncorrected)
Inclusion Criteria control group:
- Adolescents who do not have a lifetime principal diagnosis of a psychiatric disorder (ICD-10-GM-2016: F10 - F69) and are between 13 and 21 years old.
Exclusion Criteria Control Group:
dementia / below average general cognitive ability (IQ < 85)
lack of German language skills
severe impairment of vision or hearing (not corrected).
Study Design
Total Participants: 622
Study Start date:
February 20, 2023
Estimated Completion Date:
September 30, 2025
Connect with a study center
University Medical Center Hamburg-Eppendorf
Hamburg, 20251
GermanyActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.